• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-494 通过靶向 PTEN 促进肿瘤扩增髓源性抑制细胞的积累和功能。

MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.

机构信息

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, People's Republic of China.

出版信息

J Immunol. 2012 Jun 1;188(11):5500-10. doi: 10.4049/jimmunol.1103505. Epub 2012 Apr 27.

DOI:10.4049/jimmunol.1103505
PMID:22544933
Abstract

Myeloid-derived suppressor cells (MDSCs) potently suppress the anti-tumor immune responses and also orchestrate the tumor microenvironment that favors tumor angiogenesis and metastasis. The molecular networks regulating the accumulation and functions of tumor-expanded MDSCs are largely unknown. In this study, we identified microRNA-494 (miR-494), whose expression was dramatically induced by tumor-derived factors, as an essential player in regulating the accumulation and activity of MDSCs by targeting of phosphatase and tensin homolog (PTEN) and activation of the Akt pathway. TGF-β1 was found to be the main tumor-derived factor responsible for the upregulation of miR-494 in MDSCs. Expression of miR-494 not only enhanced CXCR4-mediated MDSC chemotaxis but also altered the intrinsic apoptotic/survival signal by targeting of PTEN, thus contributing to the accumulation of MDSCs in tumor tissues. Consequently, downregulation of PTEN resulted in increased activity of the Akt pathway and the subsequent upregulation of MMPs for facilitation of tumor cell invasion and metastasis. Knockdown of miR-494 significantly reversed the activity of MDSCs and inhibited the tumor growth and metastasis of 4T1 murine breast cancer in vivo. Collectively, our findings reveal that TGF-β1-induced miR-494 expression in MDSCs plays a critical role in the molecular events governing the accumulation and functions of tumor-expanded MDSCs and might be identified as a potential target in cancer therapy.

摘要

髓系来源的抑制性细胞(MDSCs)能够强烈抑制抗肿瘤免疫反应,还可以协调有利于肿瘤血管生成和转移的肿瘤微环境。调节肿瘤扩增 MDSC 积累和功能的分子网络在很大程度上是未知的。在这项研究中,我们发现了 microRNA-494(miR-494),其表达被肿瘤衍生因子显著诱导,作为通过靶向磷酸酶和张力蛋白同源物(PTEN)和激活 Akt 途径来调节 MDSC 积累和活性的重要参与者。TGF-β1 被发现是主要的肿瘤衍生因子,负责 MDSC 中 miR-494 的上调。miR-494 的表达不仅增强了 CXCR4 介导的 MDSC 趋化性,而且通过靶向 PTEN 改变了内在凋亡/存活信号,从而有助于 MDSC 在肿瘤组织中的积累。因此,PTEN 的下调导致 Akt 途径的活性增加,随后 MMPs 的上调促进肿瘤细胞的侵袭和转移。miR-494 的敲低显著逆转了 MDSC 的活性,并抑制了 4T1 小鼠乳腺癌在体内的生长和转移。总之,我们的研究结果表明,TGF-β1 诱导的 MDSC 中 miR-494 的表达在调节肿瘤扩增 MDSC 的积累和功能的分子事件中起着关键作用,可能被确定为癌症治疗的潜在靶点。

相似文献

1
MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.MicroRNA-494 通过靶向 PTEN 促进肿瘤扩增髓源性抑制细胞的积累和功能。
J Immunol. 2012 Jun 1;188(11):5500-10. doi: 10.4049/jimmunol.1103505. Epub 2012 Apr 27.
2
MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.微小RNA-200c通过调节PTEN和FOG2的表达促进髓源性抑制细胞的抑制潜能。
PLoS One. 2015 Aug 18;10(8):e0135867. doi: 10.1371/journal.pone.0135867. eCollection 2015.
3
Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.缺氧诱导的脑胶质瘤外泌体通过髓源抑制性细胞通过 miR-10a/Rora 和 miR-21/Pten 通路发挥免疫抑制作用。
Oncogene. 2018 Aug;37(31):4239-4259. doi: 10.1038/s41388-018-0261-9. Epub 2018 May 1.
4
MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells.微小 RNA-155 和微小 RNA-21 促进功能性髓源性抑制细胞的扩增。
J Immunol. 2014 Feb 1;192(3):1034-43. doi: 10.4049/jimmunol.1301309. Epub 2014 Jan 3.
5
MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1.微小RNA-9通过靶向Runx1调控髓源性抑制细胞的分化和功能。
J Immunol. 2015 Aug 1;195(3):1301-11. doi: 10.4049/jimmunol.1500209. Epub 2015 Jun 19.
6
miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.miR-223 抑制肿瘤诱导的骨髓细胞中 CD11b⁺Gr1⁺髓源抑制性细胞的分化。
Int J Cancer. 2011 Dec 1;129(11):2662-73. doi: 10.1002/ijc.25921. Epub 2011 Mar 25.
7
MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.微小RNA-155缺乏增强了肿瘤微环境中髓源性抑制细胞的募集和功能,并促进实体瘤生长。
Int J Cancer. 2015 Mar 15;136(6):E602-13. doi: 10.1002/ijc.29151. Epub 2014 Aug 30.
8
Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis.过氧化物酶体增殖物激活受体γ在髓源性抑制细胞刺激的癌细胞增殖和转移中的关键作用。
Oncotarget. 2016 Jan 12;7(2):1529-43. doi: 10.18632/oncotarget.6414.
9
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.微小 RNA-216a/217 诱导的上皮-间充质转化靶向 PTEN 和 SMAD7 促进肝癌耐药和复发。
Hepatology. 2013 Aug;58(2):629-41. doi: 10.1002/hep.26369. Epub 2013 Jun 25.
10
Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.肿瘤衍生的前列腺素 E2 的抑制作用阻断了髓源性抑制细胞的诱导,并恢复了自然杀伤细胞的活性。
Clin Cancer Res. 2014 Aug 1;20(15):4096-106. doi: 10.1158/1078-0432.CCR-14-0635. Epub 2014 Jun 6.

引用本文的文献

1
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.
2
Integrating Genomics and Molecular Biology in Understanding Peritoneal Adhesion.整合基因组学与分子生物学以理解腹膜粘连
Curr Issues Mol Biol. 2025 Jun 19;47(6):475. doi: 10.3390/cimb47060475.
3
Mir-494-3p enhances aggressive phenotype of non-small cell lung cancer cells by regulating SET/I2PP2A.
Mir-494-3p通过调控SET/I2PP2A增强非小细胞肺癌细胞的侵袭性表型。
Sci Rep. 2025 May 2;15(1):15441. doi: 10.1038/s41598-025-99558-9.
4
The epigenetic hallmarks of immune cells in cancer.癌症中免疫细胞的表观遗传特征。
Mol Cancer. 2025 Mar 5;24(1):66. doi: 10.1186/s12943-025-02255-4.
5
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.了解 TNFR2 信号在乳腺癌肿瘤微环境中的作用。
J Exp Clin Cancer Res. 2024 Nov 28;43(1):312. doi: 10.1186/s13046-024-03218-1.
6
Research progress on the role of PTEN deletion or mutation in the immune microenvironment of glioblastoma.PTEN缺失或突变在胶质母细胞瘤免疫微环境中的作用研究进展
Front Oncol. 2024 Aug 14;14:1409519. doi: 10.3389/fonc.2024.1409519. eCollection 2024.
7
MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.miRNAs 作为卵巢癌肿瘤微环境中免疫细胞的调节因子。
Cells. 2024 Aug 13;13(16):1343. doi: 10.3390/cells13161343.
8
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy.肿瘤免疫微环境代谢重编程在结直肠癌进展、免疫逃逸和免疫治疗反应中的作用。
Front Immunol. 2024 Jul 25;15:1353787. doi: 10.3389/fimmu.2024.1353787. eCollection 2024.
9
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.循环多形核髓系来源抑制细胞(PMN-MDSCs)在原发性骨髓纤维化患者中具有生物学作用。
Cancers (Basel). 2024 Jul 16;16(14):2556. doi: 10.3390/cancers16142556.
10
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review).髓源性抑制细胞作为新兴疗法和纳米疗法的靶点(综述)
Med Int (Lond). 2024 Jun 25;4(5):46. doi: 10.3892/mi.2024.170. eCollection 2024 Sep-Oct.